Vascular Disease and Surgery


Heart transplantation surgery has become the standard treatment for selected patients with end-stage heart failure. Improvements in immunosuppressant, donor procurement, surgical techniques, and post-transplant care have resulted in a substantial decrease in acute allograft rejection, which had previously significantly limited survival of heart transplant recipients.

The number of heart transplants performed worldwide over the last decade has continued to increase annually.

Current challenges include older age of both recipients and donors; an increasing number of transplants performed with mechanical circulatory support; the growing use of combined organ transplants (now more than 4% of all heart transplants); and a high proportion of sensitised patients (those with pre-formed antibodies against human leukocyte antigens, which increased the risk of organ rejection).

Related Articles


Changing the Face of Cardiovascular Care for Women

Martha Gulati, Cara Hendry, Biljana Parapid,


Citation: European Cardiology Review 2021;16:e52.

What an Interventionalist Needs to Know About INOCA

Daniel Tze Yee Ang, Colin Berry,


Citation: Interventional Cardiology 2021;16:e32.

Definitions and Epidemiology of Coronary Functional Abnormalities

Andreas Seitz, Johanna McChord, Raffi Bekeredjian,


Citation: European Cardiology Review 2021;16:e51.

Air Pollution, Inflammatory Biomarkers and Infarct Size In STEMI Patients

Laura Díaz-Chirón, Luis Negral, Laura Megido,


Citation: European Cardiology Review 2021;16:e50.